| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 46.343 | 49.677 | 53.869 | 62.395 | 77.237 | 81.402 | 103.652 | 96.383 | 133.309 | 134.971 |
| Total Income - EUR | 46.360 | 49.730 | 53.942 | 63.250 | 77.248 | 81.402 | 103.653 | 96.384 | 133.409 | 135.043 |
| Total Expenses - EUR | 37.705 | 30.609 | 33.357 | 49.751 | 60.782 | 70.251 | 93.797 | 90.861 | 99.125 | 120.041 |
| Gross Profit/Loss - EUR | 8.654 | 19.121 | 20.585 | 13.500 | 16.466 | 11.152 | 9.856 | 5.523 | 34.284 | 15.002 |
| Net Profit/Loss - EUR | 7.264 | 18.624 | 20.046 | 12.870 | 15.694 | 10.643 | 8.866 | 4.627 | 32.977 | 11.032 |
| Employees | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 4 | 4 | 5 |
Check the financial reports for the company - Medmar Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 387 | 7.661 | 5.625 | 4.329 | 2.215 | 328 | 78 | 0 | 1.765 | 23.562 |
| Current Assets | 88.107 | 91.070 | 18.167 | 28.901 | 37.156 | 43.747 | 18.661 | 13.790 | 37.759 | 24.469 |
| Inventories | 919 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 7.395 | 8.376 | 9.048 | 9.428 | 10.008 | 4.574 | 12.057 | 6.110 | 30.106 | 10.777 |
| Cash | 79.793 | 82.694 | 9.120 | 19.472 | 27.148 | 39.173 | 6.604 | 7.679 | 7.653 | 13.692 |
| Shareholders Funds | 69.184 | 18.678 | 20.098 | 12.922 | 28.365 | 10.693 | 8.914 | 4.676 | 33.025 | 11.080 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 19.310 | 80.053 | 3.694 | 20.308 | 11.006 | 33.382 | 9.825 | 9.114 | 6.499 | 36.951 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Medmar Srl